You are here
Peer-Reviewed Articles selected by Lymphoma resource centre editors Francesco Bertoni, MD and Anastasios Stathis, MD.
All journal papers are available in full text format with PDFs of the complete papers.
Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma
Diego Villa, Anupkumar George, John F. Seymour, Cynthia L. Toze, Michael Crump, Christina Lee, Rena Buckstein, Douglas A. Stewart, David MacDonald, Ronan Foley, Anargyros Xenocostas, Mitchell Sabloff, Neil Chua, Felix Couture, Jean F. Larouche, et al.Original Research Article Biology of Blood and Marrow Transplantation, In Press, Uncorrected Proof, Available online 18 July 2014
Human B-cell cancer cell lines as a preclinical model for studies of drug effect in diffuse large B-cell lymphoma and multiple myeloma
Maria Bach Laursen, Steffen Falgreen, Julie Støve Bødker, Alexander Schmitz, Malene Krag Kjeldsen, Suzette Sørensen, Jakob Madsen, Tarec Christoffer El-Galaly, Martin Bøgsted, Karen Dybkær, Hans Erik Johnsen, Myeloma Stem Cell Network (MSCNET)Review Article Experimental Hematology, In Press, Accepted Manuscript, Available online 27 July 2014
Autologous Transplantation for Transformed Non-Hodgkin Lymphoma Using an Yttrium-90 Ibritumomab Tiuxetan Conditioning Regimen
Matthew Mei, Marielle J. Wondergem, Joycelynne M. Palmer, Avichai Shimoni, Justin Hasenkamp, Ni-Chun Tsai, Jennifer Simpson, Auayporn Nademanee, Andrew Raubitschek, Stephen J. Forman, Amrita Y. KrishnanBiology of Blood and Marrow Transplantation, In Press, Uncorrected Proof, Available online 29 July 2014
- Review Article Critical Reviews in Oncology/Hematology, In Press, Corrected Proof, Available online 30 July 2014
FDG PET/MR for the Assessment of Lymph Node Involvement in Lymphoma : Initial Results and Role of Diffusion-Weighted MR
Ivan Platzek, Bettina Beuthien-Baumann, Rainer Ordemann, Jens Maus, Georg Schramm, Hagen H. Kitzler, Michael Laniado, Jörg Kotzerke, Jörg van den HoffOriginal Research Article Academic Radiology, In Press, Corrected Proof, Available online 30 July 2014
- Experimental Hematology, Volume 42, Issue 8, Supplement, August 2014, Page S61
Low-Dose Chest Computed Tomography for Lung Cancer Screening Among Hodgkin Lymphoma Survivors: A Cost-Effectiveness Analysis
Daniel A. Wattson, M.G. Myriam Hunink, Pamela J. DiPiro, Prajnan Das, David C. Hodgson, Peter M. Mauch, Andrea K. NgOriginal Research Article International Journal of Radiation Oncology*Biology*Physics, In Press, Corrected Proof, Available online 4 August 2014
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study
Anas Younes, Catherine Thieblemont, Franck Morschhauser, Ian Flinn, Jonathan W Friedberg, Sandy Amorim, Benedicte Hivert, Jason Westin, Jessica Vermeulen, Nibedita Bandyopadhyay, Ronald de Vries, Sriram Balasubramanian, Peter Hellemans, Johan W SmitOriginal Research Article The Lancet Oncology, Volume 15, Issue 9, August 2014, Pages 1019-1026
Targeting the B-cell receptor signaling represents one of the most promising approach for B-cell derived lymphoid neoplasms. The data so far published with the PI3K-delta inhibitor idelalisib and with the BTK-inhibitor ibrutinib as single agents are interesting although it is logic to combine them with conventional or other targeted compounds. Here, Younes and Coll. presents the phase 1 study of ibrutinib combined with the standard regimen R-CHOP in patients with untreated CD20+ B cell lymphomas. The regimen was well tolerated and active. Importantly, there were more responses in activated B cell-like A(BC) diffuse large B cell (DLBCL) lymphomas than among the germinal center B cell (GCB) type DLBCL, in accordance with the previous pre-clinical and clinical reports.
R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma
Zachary Frosch, Marlise R. Luskin, Daniel J. Landsburg, Stephen J. Schuster, Jakub Svoboda, Alison W. Loren, David L. Porter, Edward A. Stadtmauer, Sunita D. Nasta
Clinical Lymphoma Myeloma and Leukemia
Andrew C. Cannon, Fausto R. Loberiza Jr.
Clinical Lymphoma Myeloma and Leukemia